Explore UAB

UAB News Stay informed with the latest updates
Articles Tagged
News You Can Use Published 2 days ago

Learn about epilepsy, types of seizures, common symptoms, warning signs and how to provide seizure first aid.

Health & Medicine Published 27 days ago

UAB experts offer insight on Tourette syndrome, and the care patients may need after diagnosis.

Research & Innovation Published 36 days ago

Until now, treatments have only managed symptoms, rather than altering the disease’s course.

Health & Medicine Published 41 days ago

New clinical services and specialty programs are expanding access to high-quality care in Birmingham and throughout Alabama.

News You Can Use Published 63 days ago

A UAB neurologist shares how symptoms of various movement disorders can be treated with deep brain stimulation therapy.

Research & Innovation Published 3 months ago

The published study found a correlation between first-time transient ischemic attack and future cognitive decline. Rates of decline between TIA and stroke participants were the same.

News You Can Use Published 4 months ago

Knowing the symptoms and acting quickly in a stroke emergency can help to minimize long-term effects.

News You Can Use Published 6 months ago

Chronic stress can increase inflammation in the brain, which can impact sleep, cognition and memory and potentially increase one’s risk for neurodegenerative diseases.

Photo of the Killian family.
Health & Medicine Published 6 months ago

The Killion family of Birmingham has given a $10 million gift to UAB to create the Wayne Killion Endowment for the Center for Neurodegeneration and Experimental Therapeutics and to rename the center the Killion Center for Neurodegeneration and Experimental Therapeutics.

Health & Medicine Published 7 months ago

Via virtual submissions, UAB Medicine now offers remote second opinions from specialized care experts on diagnoses and treatment options.

Research & Innovation Published 10 months ago

Rachel Smith, Ph.D., is collaborating with researchers across UAB on the two-year project, which will focus on the intracranial neural networks responsible for major depressive symptoms in epilepsy patients. 

Health & Medicine Published 11 months ago

UAB was among the first medical centers in the country to obtain a MEG, having done so originally in 2001; however, evolving technology has created a need for replacing the old technology with a new one.

Research & Innovation Published more than a year ago

This is a step toward an understanding of the brain that ultimately describes the mechanistic basis of human cognition and behavior.

Health & Medicine Published more than a year ago

Leveraging the existing Alabama Trauma and Statewide Stroke systems, UAB and ADPH have created a model for a more integrated and effective system of emergency stroke care.

Research & Innovation Published more than a year ago

Results suggest that, rather than stimulating both sides of the brain using DBS, unilateral right DBS may avoid DBS-related declines in verbal fluency and response inhibition in patients with movement disorders like Parkinson’s disease.

Research & Innovation Published more than a year ago

Blazer Bridge Fund provides financial support to innovative ideas and inventions by the UAB community, encouraging advanced discovery. 

Health & Medicine Published more than a year ago

UAB Medicine has received the American Heart Association’s Get With The Guidelines® - Stroke Gold Plus with the added distinctions of Target: Stroke℠ Honor Roll Elite Plus and Target: Type 2 Diabetes™ Honor Roll.

Research & Innovation Published more than a year ago

This finding suggests that therapy to remodel synapses could help memory in old age and dementia patients.

Health & Medicine Published more than a year ago

For 11 consecutive years, U.S. News has named UAB Hospital the best hospital in Alabama, with several specialties and procedures ranked among the best.

Research & Innovation Published more than a year ago

By prohibiting the Activin A protein from functioning, researchers were able to halt the development of dyskinesia symptoms and effectively erase the brain’s “bad memory” response to L-DOPA treatments.

Page 1 of 4

Back to Top